Novotech News
-
Novotech Expands South Korean Presence With New Hospital Trial Site Deal
4/4/2025
Australian CRO Novotech has signed a memorandum of understanding with the Kyungpook National University Hospital (KNUH), furthering its partnership strategy in South Korea.
-
Novotech Named Best Contract Research Organization In Australia At Asia-Pacific Biopharma Excellence Awards 2025
4/3/2025
Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company that provides biotech and small- to mid-sized pharma companies an accelerated path to market has been recognized as the Best Contract Research Organization in Australia at the Asia-Pacific Biopharma Excellence Awards (ABEA) 2025.
-
Novotech Report Reveals Growth In siRNA Research
4/3/2025
Sydney, March 2025 – Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of small interfering RNA (siRNA) therapeutics. This report provides insights for biotech and pharmaceutical companies leveraging RNA-based precision medicine to develop next-generation treatments for oncology, metabolic disorders, and rare genetic diseases.
-
Novotech Partners With Kyungpook National University Hospital To Strengthen Clinical Trial Capabilities In South Korea
3/19/2025
Novotech, a global leading full-service clinical CRO, and Acrostar, a provider of Site Management Organization (SMO) services, have entered into a strategic partnership that will support clinical trials across NHUH’s prestigious institutions including the Advanced Clinical Trials Center, the KNUH main campus, and the Chilgok KNUH in South Korea.
-
Novotech Releases Comprehensive Report On Oncolytic Virus Therapy
1/30/2025
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech and small to mid-size pharma companies to accelerate the development of advanced and novel therapeutics, has released its latest report, Oncolytic Virus Therapy: Global Clinical Trial Landscape 2024. This comprehensive whitepaper analyzes the evolving landscape of oncolytic virus therapies (OVT), providing critical insights into this transformative approach to cancer treatment.
-
Novotech Releases Report On Current State Of Triple-Negative Breast Cancer Clinical Trials
1/30/2025
Novotech, the leading global full-service clinical Contract Research Organization (CRO), has released a comprehensive report analyzing the global clinical trial and drug development landscape for Triple-Negative Breast Cancer (TNBC). The report highlights significant advancements in therapeutic strategies, regional clinical trial activity, and evolving biomarkers driving innovative TNBC treatments.
-
Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape
12/30/2024
Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024. This report provides critical insights into the trends, opportunities, and challenges in Parkinson's disease (PD) research, serving as a valuable resource for companies developing treatments for this complex neurodegenerative disorder.
-
Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories
12/30/2024
Novotech has announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.
-
Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape
12/30/2024
The global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report "COVID-19: Global Clinical Trial Landscape 2024."
-
Novotech Publishes Comprehensive Report On The Global Vaccine Clinical Trials Landscape
12/4/2024
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders.